Healthcare Sales & Marketing Network News: biodegradable

Searching News Database: biodegradable

HSMN NewsFeed - 22 Nov 2024
Bioretec Signed a New Sales and Distribution Agreement to Accelerate the Commercialization of RemeOs(TM) Trauma Screw in the U.S. Civilian Hospital Market
Devices Orthopaedic Distribution

HSMN NewsFeed - 2 Oct 2023
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 14 Sep 2023
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
Devices Interventional Cardiology

HSMN NewsFeed - 31 May 2023
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
Devices Interventional

HSMN NewsFeed - 14 Mar 2023
Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study
Devices Interventional Cardiology

HSMN NewsFeed - 25 Jan 2023
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
Devices Interventional Cardiology

HSMN NewsFeed - 11 Jan 2023
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval
Devices Interventional Cardiology FDA

HSMN NewsFeed - 25 Oct 2022
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
Devices Interventional Cardiology FDA

HSMN NewsFeed - 18 Oct 2022
Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology
Devices Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 18 Oct 2022
MedAlliance to be Acquired by Cordis
Devices Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 13 Oct 2021
Poseida Therapeutics Announces Leadership Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2021
18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR(TM) Presented as Late Breaking Trial at VIVA
Devices Interventional

HSMN NewsFeed - 13 Jul 2021
Stryker announces the FDA clearance of the first biodegradable subacromial balloon spacer, filling a gap in the shoulder continuum of care
Devices Orthopaedic FDA

HSMN NewsFeed - 4 Mar 2021
MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology FDA

HSMN NewsFeed - 21 Oct 2020
Acuitive Technologies Granted FDA 510(k) Clearance for CITREGEN(TM) CITRELOCK(TM) Tendon Interference Screw System
Devices Orthopaedic FDA

HSMN NewsFeed - 23 Sep 2020
OrbusNeich(R) Announces China Approval for COMBO(R) Coronary Stent
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 Jul 2020
Exero Medical Completes First In-Human Implant of Wireless Anastomotic Leak Sensor at Rabin Medical Center
Devices Gastroenterology Surgery

HSMN NewsFeed - 15 Jul 2020
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
Devices Interventional Oncology Mergers & Acquisitions

HSMN NewsFeed - 10 Jul 2020
World's First FDA IDE Coronary Patient Treated With a DEB
Devices Interventional Cardiology

HSMN NewsFeed - 30 Jun 2020
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 25 Sep 2019
OrbusNeich(R) Announces Japan Approval for COMBO(R) Plus Coronary Stent
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 22 Jul 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Jul 2019
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 15 Oct 2018
Palette Life Sciences and Nestlé Skin Health Enter into Global Licensing Agreement for Deflux(R), Solesta(R) and Barrigel(TM)
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 May 2018
Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 5 Dec 2017
Lia Diagnostics Announces FDA Clearance Of The First And Only Flushable, Biodegradable Pregnancy Test
Diagnostics FDA

HSMN NewsFeed - 30 Dec 2016
Innocoll Receives Refusal to File Letter from U.S. FDA for XARACOLL(R) (bupivacaine HCl collagen-matrix implants) New Drug Application
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 17 May 2016
MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
Regenerative Medicine Wound Care Litigation

HSMN NewsFeed - 23 Mar 2016
Envisia Therapeutics Secures $16.5 Million In Additional Series A Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 23 Oct 2015
InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold(TM)
Devices Neurosurgery

HSMN NewsFeed - 14 May 2015
InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold
Devices Neurosurgery

HSMN NewsFeed - 1 Apr 2015
InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold
Devices Neurosurgery Neurology

HSMN NewsFeed - 1 Apr 2015
Corium Announces Appointment of Eric H. Bjerkholt to Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 2 Mar 2015
Mersana Raises $35 Million in Series B Financing and Appoints Anna Protopapas as President and Chief Executive Officer
Devices Drug Delivery Venture Capital Personnel

HSMN NewsFeed - 3 Feb 2015
CTI BioPharma Announces Independent DMC Recommendation to Continue GOG-0212 Phase 3 Study of OPAXIO(TM) as Maintenance Therapy in Ovarian Cancer, an NRG Oncology/GOG Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Jan 2015
Gecko Biomedical Receives 1.3 Million Euros From Bpifrance to Advance its Bio-Inspired Surgical Adhesive Solutions
Devices Surgery Venture Capital

HSMN NewsFeed - 16 Jan 2015
ECA Medical Instruments Develops First Disposable Spinal Instrument Fixation Kit to Gain FDA Approval with Intelligent Implant Systems
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 2 Dec 2014
Xeltis Closes EURO 27 Million / USD 34 Million Series B Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 29 Sep 2014
Allergan Announces FDA Approves Revised Indication for OZURDEX(R) (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Drug Delivery FDA

HSMN NewsFeed - 18 Sep 2014
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
Devices Interventional Cardiology

HSMN NewsFeed - 16 Jul 2014
First Patient Enrolment in MASCOT Registry Represents Major Milestone for COMBO(TM) Dual Therapy Stent and OrbusNeich's Clinical Programme
Devices Interventional Cardiology

HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 23 May 2014
OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
Devices Interventional Cardiology

HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 9 Dec 2013
Gecko Biomedical Raises €8 Million in Series A Financing to Advance Next-generation Tissue Adhesives for Wound Closure During Open and Minimally Invasive Surgery
Devices Wound Care Venture Capital

HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology

HSMN NewsFeed - 6 Aug 2013
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent(TM) in Routine Practice
Devices Interventional Cardiology

HSMN NewsFeed - 1 Aug 2013
First U.S. Cases Using KARL STORZ RECON Diamond TwInS Instruments for Ankle Surgery
Devices Orthopaedic

HSMN NewsFeed - 27 May 2013
OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 24 May 2013
Elixir Medical Corporation Announces Outstanding Two-Year Results from the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne(R) BD System with Biodegradable Polymer Coating
Devices Interventional Cardiology

HSMN NewsFeed - 21 Jan 2013
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
Devices Interventional Cardiology

HSMN NewsFeed - 17 Jan 2013
Milestone Orthopedic Procedures Performed at UNC & Duke Hospitals Using KARL STORZ Technologies
Devices Orthopaedic Surgery

HSMN NewsFeed - 27 Nov 2012
Carbylan Biosurgery, Inc. and Shanghai Jingfeng Pharmaceutical Corporation Announce License Agreement
Biopharmaceuticals Devices Orthopaedic Licensing

HSMN NewsFeed - 16 Oct 2012
OrbusNeich's COMBO Dual Therapy Stent(TM) to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012
Devices Interventional Cardiology

HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Aug 2012
Elixir Medical Receives CE Mark Approval for the DESyne(R) BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 8 Aug 2012
Cardionovum(R) Expects to Launch Next-Generation Product: Drug-Eluting Coronary Stent System, “PROLIMUS Biograde”
Devices Interventional Cardiology

HSMN NewsFeed - 25 Jul 2012
NuPathe Appoints Armando Anido as Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2012
Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD(TM) Novolimus Eluting Coronary Stent with Biodegradable Polymer
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2012
Piramal Healthcare Presents Positive Results of Pivotal Phase III Clinical Trial for BST-CarGel(R) at the World Congress of the International Cartilage Repair Society (ICRS)
Devices Orthopaedic

HSMN NewsFeed - 9 Mar 2012
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 22 Feb 2012
Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease
Devices Drug Delivery Venture Capital

HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Devices Distribution

HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Devices Surgery Regulatory

HSMN NewsFeed - 2 Aug 2011
Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans
Devices Wound Care FDA

HSMN NewsFeed - 21 Jun 2011
Bydureon Receives Marketing Authorization in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 Apr 2011
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2011
BYDUREON Recommended for Approval in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 12 Apr 2011
Bone Solutions Inc. plans pivotal study of OsteoCrete(TM) for spinal fusion indication following constructive pilot study results, while preparing to launch OsteoCrete(TM) as an FDA-cleared bone void filler
Devices Orthopaedic

HSMN NewsFeed - 22 Nov 2010
Paclitaxel Poliglumex (OPAXIO(R)) Combined with Temozolomide and Radiotherapy Demonstrates High Response Rates with Encouraging Progression Free Survival in Malignant Brain Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Nov 2010
PDS(TM) Flexible Plate, a Unique Absorbable Implant, for Nasal Reconstruction, Now Available in the U.S.
Devices Surgery

HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Aug 2010
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Biopharmaceuticals

HSMN NewsFeed - 13 Aug 2010
First Patient Treated with Drug Eluting Absorbable Metal Scaffold in the BIOTRONIK "BIOSOLVE-I" Clinical Study
Devices Interventional Cardiology

HSMN NewsFeed - 15 Apr 2010
Silence Therapeutics Appoints Max Herrmann as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Apr 2010
Selecta Closes $15 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jan 2010
DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 5 Jan 2010
Cardium to Launch MedPodium(TM) Product Line Initially Covering Six New Advanced Foot Care Products for Podiatry Patients to Complement the Excellagen Platform
Devices Wound Care

HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 3 Dec 2009
Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Devices Wound Care FDA

HSMN NewsFeed - 1 Dec 2009
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
Biopharmaceuticals Ophthalmology Drug Delivery Licensing

HSMN NewsFeed - 18 Jun 2009
Allergan Receives FDA Approval for OZURDEX Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 8 Jun 2009
Bone Solutions Inc. (BSI) receives FDA 510(K) clearance for world's first and only magnesium-based bone void filler, OsteoCrete
Devices Orthopaedic FDA

HSMN NewsFeed - 21 May 2009
AMG International Announces the European Regulatory Submission of its Next Generation of Coronary Drug Stents 'Itrix' at European PCR Congress in Barcelona, Spain
Device,s Interventional Cardiology

HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2009
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2009
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 27 Apr 2009
RISPERDAL CONSTA Approved in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Mar 2009
Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
Devices Wound Care

HSMN NewsFeed - 19 Mar 2009
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 10 Feb 2009
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jan 2009
Boston Scientific Acquires Labcoat Limited
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 17 Nov 2008
Innocoll Receives Fast Track Designation for Gentamicin Surgical Implant
Devices Drug Delivery FDA

HSMN NewsFeed - 4 Nov 2008
SurModics Acquires Drug Delivery Assets of PR Pharmaceuticals
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 13 Oct 2008
Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
Devices Interventional Cardiology

HSMN NewsFeed - 10 Oct 2008
Elixir Medical Corporation Licenses Myolimus(TM) From Novartis Pharma AG for Site-Specific Drug Delivery Applications
Devices Drug Delivery Licensing Interventional Cardiology

HSMN NewsFeed - 2 Oct 2008
Intradigm Raises $18.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Sep 2008
Merck & Co., Inc. Discontinues License and Research Collaboration Agreement with SurModics
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 15 Sep 2008
7 Health Ventures Invests in Tulip Medical
Devices Venture Capital

HSMN NewsFeed - 1 Sep 2008
Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study
Devices Interventional Cardiology

HSMN NewsFeed - 26 Aug 2008
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 25 Aug 2008
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 5 Aug 2008
Craig W. Philips Takes Helm at CTI
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2008
Inion Receives 510(k) Marketing Clearance to Sell its Biodegradable Graft Containment Systems in the USA for Spinal Fusion Procedures
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 7 Jul 2008
Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Jun 2008
Indevus Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2008
Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
Biopharmaceuticals FDA

HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Biopharmaceuticals Licensing Urology

HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology

HSMN NewsFeed - 6 May 2008
Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 5 May 2008
European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics' Lung Cancer Drug
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 29 Apr 2008
Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
Devices Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 23 Apr 2008
Adhezion Biomedical Completes Series A Financing
Devices Venture Capital

HSMN NewsFeed - 16 Apr 2008
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2008
European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 31 Mar 2008
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 31 Mar 2008
SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 4 Mar 2008
Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 27 Feb 2008
JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
Biopharmaceuticals Dermatology

HSMN NewsFeed - 12 Feb 2008
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2008
Aporo Biomedical Announces Global Licensing Agreement for Proprietary Polymers Used to Treat Structural Heart Disease
Devices Interventional Cardiology Licensing

HSMN NewsFeed - 18 Jan 2008
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 17 Jan 2008
TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(k) Clearance of the AIGIS(Rx)(TM) Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacem
Devices Biopharmaceuticals FDA Cardiology

HSMN NewsFeed - 16 Jan 2008
Mersana Therapeutics, Inc. Appoints John H. van Duzer, Ph.D., as Vice President of Manufacturing and Pharmaceutical Sciences
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2008
Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 8 Jan 2008
TyRx Pharma, Inc. Announces the Appointment of Robert M. (Bob) Mattioli as Vice President, Commercial Development
Devices Personnel

HSMN NewsFeed - 4 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Devices Surgery Pain Management

HSMN NewsFeed - 3 Jan 2008
Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Regenerative Medicine Urology

HSMN NewsFeed - 2 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Devices Surgery

HSMN NewsFeed - 27 Dec 2007
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 18 Dec 2007
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Drug Delivery Wound Care

HSMN NewsFeed - 18 Dec 2007
Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 22 Oct 2007
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 17 Oct 2007
Innocoll Files Investigational New Drug Application for its CollaRx(R) BUPIVACAINE TOPICAL for the Treatment of Painful Chronic Skin Ulcers and Burns
Biopharmaceuticals Wound Care

HSMN NewsFeed - 15 Oct 2007
Tengion Closes $33 Million in Series C Funding
Regenerative Medicine Venture Capital

HSMN NewsFeed - 24 Sep 2007
Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Sep 2007
Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Regenerative Medicine Urology

HSMN NewsFeed - 12 Sep 2007
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
Biopharmaceuticals Drug Delivery Wound Care

HSMN NewsFeed - 6 Sep 2007
Innocoll, Inc. and Bourne Partners Announce Joint Venture to Build Leading U.S. Advanced Wound Care Business
Devices Wound Care

HSMN NewsFeed - 6 Sep 2007
Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Biopharmaceuticals Surgery Acquisitions

HSMN NewsFeed - 8 Aug 2007
Health Canada Approves Innocoll's CollaRx(R) GENTAMICIN SURGICAL IMPLANT
Devices Regulatory

HSMN NewsFeed - 1 Aug 2007
SurModics Acquires Brookwood Pharmaceuticals
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Obtains FDA Clearance to Market CryoSeal(R) Fibrin Sealant (FS) in Liver Resection Surgeries
Devices FDA Surgery

HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer and Director
Devices Personnel

HSMN NewsFeed - 12 Jul 2007
Mersana Therapeutics, Inc. Appoints Pharmaceutical Industry Veteran Nicholas G. Bacopoulos, Ph.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2007
Innocoll Announces Filing of Investigational New Drug Application for its CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 5 Jun 2007
XYOTAX(TM) More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Endovasc Announces Formation of BioFlow, Inc.
Devices

HSMN NewsFeed - 4 Jun 2007
Pre-menopausal Estrogen Levels Linked to Higher Death Rate Among Women Receiving Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 May 2007
Smith & Nephew and Teknimed SA Enter Into Global Distribution Agreement to Treat Compression Fractures in Spine
Devices Orthopaedic Neurosurgery Distribution

HSMN NewsFeed - 10 May 2007
Angiotech to market Vascular Wrap(TM)/ePTFE graft combination product through its own European sales and distribution networks
Devices Distribution

HSMN NewsFeed - 26 Apr 2007
Two-year data for Angiotech's Vascular Wrap(TM) Paclitaxel-Eluting Mesh to be presented at European vascular symposium
Devices

HSMN NewsFeed - 24 Apr 2007
Innocoll Announces Outcome of FDA Meeting to Commence Phase 3 Development of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Devices Surgery FDA

HSMN NewsFeed - 16 Apr 2007
Aeris Therapeutics Strengthens Management Team
Devices Drug Delivery Personnel

HSMN NewsFeed - 13 Apr 2007
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Apr 2007
Cell Therapeutics, Inc. (CTI) Announces XYOTAX(TM) Has Fast Track Designation for Women With Advanced Lung Cancer Who Are Performance Status 2 (PS2)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Apr 2007
Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results
Biopharmaceuticals Dermatology

HSMN NewsFeed - 4 Apr 2007
Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery

HSMN NewsFeed - 29 Mar 2007
Innocoll Files US and Irish Patent Applications for its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery

HSMN NewsFeed - 22 Mar 2007
Innocoll Files CollaRx(R) GENTAMICIN SURGICAL IMPLANT in Canada and Receives Canadian Medical Devices Conformity Assessment System (CMDCAS) Certification
Devices Regulatory

HSMN NewsFeed - 20 Mar 2007
Cell Therapeutics Inc. (CTI) Files for Special Protocol Assessment (SPA) for XYOTAX(TM) PGT307 Lung Cancer Trial in Women
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Mar 2007
Angiotech Initiates U.S. Pivotal Trial for the Vascular Wrap(TM) Paclitaxel-Eluting Mesh
Devices Interventional

HSMN NewsFeed - 26 Feb 2007
'Encouraging' Major Responses Seen With XYOTAX(TM) in Patients With Taxane-Resistant Androgen Independent Prostate Cancer
Biopharmaceuticals

HSMN NewsFeed - 5 Feb 2007
Innocoll Receives BfArM Approval for a New Version of its CollaRx(R) Gentamicin Surgical Implant in Germany
Devices Surgery Regulatory

HSMN NewsFeed - 29 Jan 2007
DURECT Signs POSIDUR(TM) Manufacturing Agreement with Hospira
Biopharmaceuticals

HSMN NewsFeed - 24 Jan 2007
MediVas Announces Signing of Collaboration Agreement With Pfizer
Biopharmaceuticals Drug Delivery Ophthalmology

HSMN NewsFeed - 24 Jan 2007
DURECT Amends Agreement with Voyager Governing Memryte(TM)
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 22 Jan 2007
Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers with Its CollaRx(R) GENTAMICIN
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jan 2007
Candela Secures Exclusive Rights to Develop Tattoo Removal Device for Freedom-2 Tattoos
Devices Dermatology

HSMN NewsFeed - 17 Jan 2007
Innocoll Announces Expansion of Distribution Partnership for its CollaRx(R) GENTAMICIN SURGICAL IMPLANT With BurnsAdler to Include Brazil and Dominican Republic and a Separate Promotional Agreement Between BurnsAdler and Serral for Same Product in Mexico
Devices Distribution

HSMN NewsFeed - 5 Jan 2007
Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
Regenerative Medicine Urology

HSMN NewsFeed - 12 Dec 2006
Indevus Pharmaceuticals to Acquire Valera Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Nov 2006
DURECT and Nycomed Sign $202 Million Agreement to Develop and Commercialize POSIDUR(TM) in Europe and Other Select Countries
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2006
Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting
Biopharmaceuticals Neurosurgery Oncology

HSMN NewsFeed - 16 Nov 2006
Angiotech submits application for European regulatory approval for its Vascular Wrap(TM) product
Devices Drug Delivery Regulatory

HSMN NewsFeed - 14 Nov 2006
Bone Solutions Inc. appoints Stephen A. Schendel, MD, DDS, Professor of Plastic and Reconstructive Surgery at Stanford University Medical Center, as its Chief Medical Officer
Devices Orthopaedic Personnel

HSMN NewsFeed - 9 Nov 2006
Innocoll Announces Investigational New Drug Application Filing for its CollaRx GENTAMICIN as a Topical Treatment for Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care

HSMN NewsFeed - 9 Nov 2006
Angiotech's Vascular Wrap(TM) trial results demonstrate reduced incidence of amputation
Devices

HSMN NewsFeed - 3 Nov 2006
Cell Therapeutics, Inc. (CTI) Temporarily Suspends Enrollment on PIONEER Lung Cancer Clinical Trial; Current Patients Continue to Be Treated
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Nov 2006
Cohera Medical, Inc. Announces Dr. Doros Platika Elected as Chairman of the Board of Directors
Devices Surgery Personnel

HSMN NewsFeed - 16 Oct 2006
TyRx Pharma, Inc. Announces Submission of a Premarket Application for PIVIT(TM) CRM, an Innovative Mesh Pouch Designed to Hold and Reduce Bacterial Colonization of a Pacemaker or Implantable Defibrillator Pulse Generator (ICD) When Implanted in the Body
Devices Cardiology FDA

HSMN NewsFeed - 12 Oct 2006
Innocoll, Inc. Receives FDA Approval For CollaGUARD(TM), A Collagen-Based Advanced Wound Care Product
Devices Wound Care

HSMN NewsFeed - 26 Sep 2006
Amaranth Medical Closes $7.5 Million Series A Financing to Advance the Development of Bio-Absorbable Stents
Devices Interventional Venture Capital

HSMN NewsFeed - 18 Sep 2006
Cell Therapeutics Inc. Announces Worldwide License and Co-Development Agreement for Development and Commercialization of XYOTAX(TM), an Investigational Agent for Treatment of Women with Non-small Cell Lung Cancer and Other Cancers
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 24 Jul 2006
TyRx Pharma, Inc., Announces FDA Clearance of PIVIT(TM) AB, a Novel Antimicrobial-Coated Surgical Mesh
Devices Surgery FDA

HSMN NewsFeed - 20 Jul 2006
Angiotech Selects Independent Sales Rep in Japan for Contour Threads(TM) Product Line
Devices Distribution

HSMN NewsFeed - 28 Jun 2006
Angiotech Pharmaceuticals Completes Acquisition of Quill Medical, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 26 Jun 2006
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2006
Cell Therapeutics, Inc. (CTI) and FDA Agree on NDA Filing Strategy for XYOTAX(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 May 2006
Leuprolide Acetate Stabilizes Cognitive and Functional Decline in Women With Alzheimer's Disease, Study Shows
Biopharmaceuticals Neurology

Return to NewsFeed

Additional items found! 182

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 182 additional stories matching:
biodegradable
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.